Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
An announcement from Chaoju Eye Care Holdings Ltd. ( (HK:2219) ) is now available.
Chaoju Eye Care Holdings Limited has scheduled a board meeting for 31 March 2026 to review and approve the group’s annual results for the year ended 31 December 2025 and to authorize their publication. The board will also deliberate on whether to recommend a final dividend, a decision that could signal management’s confidence in the group’s financial performance and influence shareholder returns.
The announcement also reaffirms the current composition of Chaoju Eye Care’s board, detailing its mix of executive, non-executive and independent non-executive directors led by chairman Zhang Bozhou. This governance disclosure underscores the company’s adherence to Hong Kong listing standards and provides investors with clarity on the leadership team guiding its strategic and financial decisions.
The most recent analyst rating on (HK:2219) stock is a Hold with a HK$3.00 price target. To see the full list of analyst forecasts on Chaoju Eye Care Holdings Ltd. stock, see the HK:2219 Stock Forecast page.
More about Chaoju Eye Care Holdings Ltd.
Chaoju Eye Care Holdings Limited is a Hong Kong–listed ophthalmic medical services group incorporated in the Cayman Islands, operating through subsidiaries under stock code 2219. The company focuses on eye care and related medical services, overseen by a board comprising executive, non-executive and independent non-executive directors, and chaired by Zhang Bozhou.
Average Trading Volume: 464,606
Technical Sentiment Signal: Strong Sell
Current Market Cap: HK$1.81B
For detailed information about 2219 stock, go to TipRanks’ Stock Analysis page.